These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22931415)

  • 1. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
    Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
    Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
    Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
    PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human skin-derived fibroblasts used as a 'Trojan horse' for drug delivery.
    Coccè V; Vitale A; Colombo S; Bonomi A; Sisto F; Ciusani E; Alessandri G; Parati E; Brambilla P; Brambilla M; La Porta CA; Pessina A
    Clin Exp Dermatol; 2016 Jun; 41(4):417-24. PubMed ID: 26899383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
    Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
    Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.
    Pessina A; Coccè V; Pascucci L; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Crovace A; Falchetti ML; Zicari S; Caruso A; Navone S; Marfia G; Benetti A; Ceccarelli P; Parati E; Alessandri G
    Br J Haematol; 2013 Mar; 160(6):766-78. PubMed ID: 23293837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
    Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
    Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.
    Choi MS; Kim SH; Kuh HJ
    Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
    Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
    Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    Scioli MG; Artuso S; D'Angelo C; Porru M; D'Amico F; Bielli A; Gentile P; Cervelli V; Leonetti C; Orlandi A
    PLoS One; 2018; 13(9):e0203426. PubMed ID: 30192811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
    Yuan L; Chen W; Hu J; Zhang JZ; Yang D
    Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB.
    Chiang HS; Wu WB; Fang JY; Chen DF; Chen BH; Huang CC; Chen YT; Hung CF
    Life Sci; 2007 Nov; 81(21-22):1509-17. PubMed ID: 17950366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo.
    Guo DD; Xu CX; Quan JS; Song CK; Jin H; Kim DD; Choi YJ; Cho MH; Cho CS
    Biomaterials; 2009 Sep; 30(27):4777-85. PubMed ID: 19524293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
    Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
    Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.